This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Intestinal infection
  • /
  • Bezlotoxumab for the prevention of Clostridium dif...

Bezlotoxumab for the prevention of Clostridium difficile recurrence.

Read time: 1 mins
Published:13th Aug 2017
Author: Couture-Cossette A, Carignan A, Ilangumaran S, Valiquette L.
Availability: Pay for access, or by subscription
Ref.:Expert Opin Biol Ther. 2017:1-7.
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest